Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly, openWorld, idempotent, and non-destructive. The description adds meaningful behavioral context: it fans out across multiple sources, reports sources_used and sources_failed, treats empty sections as real no-data results, and returns resolved:false with an explicit notes line for private companies. It also mentions the USPTO PatentsView sunset soft-fail behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is information-dense but structurally messy: it mixes examples, source lists, output field explanations, and edge-case notes into one long run-on paragraph. It front-loads common queries well, but the garbled middle section hurts readability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given there is no output schema, the description does an excellent job of explaining what the agent should expect: resolved entity info, recent filings with URIs, fundamentals, source success/failure tracking, and private-company behavior. It also covers input format flexibility and failure semantics, so the agent can call and interpret the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description adds value beyond the schema by explaining that type and value are interchangeable, that names resolve via SEC EDGAR's company-name match, and by giving concrete examples like AAPL, 0000320193, and Moderna.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's function: produce a full cross-source profile of a US public company in one parallel call. It names the specific resource (entity) and the action (profile/brief/rundown) and distinguishes it from chaining single-pack SEC/XBRL/news lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says to prefer this tool over chaining separate SEC/XBRL/news lookups when the user asks for a holistic view. It also specifies accepted inputs (ticker, CIK, company name) and notes the behavior for private companies, giving clear when-to-use and how-to-use guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation4/5

Most tools have distinct purposes, but ask_pipeworx and ask_pipeworx_grounded overlap in routing (differ only in answer mode), and the multiple Polymarket tools (bet_research, polymarket_arbitrage, polymarket_edges, polymarket_kalshi_spread) could cause confusion without careful reading of descriptions.

Naming Consistency3/5

Naming mix of verb-first (ask_pipeworx, compare_entities) and noun-first (entity_profile, recent_changes) patterns. Most use snake_case consistently, but the pattern is not uniform—some tools are commands, others are descriptors. Notable deviations like 'pipeworx_feedback' and 'pmc' are missing here but the sample shows inconsistency.

Tool Count3/5

30 tools is on the high side, but the server covers a broad domain (data lookup, betting, AI, genomics, memory). Some tools could be merged (e.g., ask_pipeworx and its grounded variant), and the betting subdomain feels over-instrumented. The count is borderline between appropriate and heavy.

Completeness3/5

The server provides a wide range of operations for its diverse domains, but gaps exist: the genomics tools only offer basic metadata search (no download/analysis), and the betting tools lack historical data or backtesting. It covers common patterns but with notable omissions for a cohesive experience.